Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05536609
Other study ID # COPS - RCT dig nerve injuries
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 29, 2022
Est. completion date September 1, 2025

Study information

Verified date October 2023
Source Karolinska Institutet
Contact Carin Carlsson, MD
Phone +46 8 123 616 00
Email carin.carlsson@regionstockholm.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Nerve injury in the fingers is a common injury and affects people of all ages. The treatment usually offered to patients is surgery and various types of rehabilitation. There is a lack of knowledge and research on how these injuries should be treated in the best way and how well sensory function can be restored after an injury. In this research project, we will investigate results after treatment for digital nerve injuries by entailing a randomised controlled trial allocating patients with isolated digital nerve injuries to either surgical repair or non-operative treatment in a cast. Primary outcome is digital nerve function as measured by 2-points discrimination at 1 year after treatment. Secondary outcomes include finger mobility, dexterity, handfunction, occurence of pain and anxiety and time on sick leave.


Description:

Patients over the age of 20 with an acute traumatic isolated digital nerve injury to any of the fingers and not in the thumb will be investigated for inclusion in the study. After informed written consent a sealed envelope randomisation will allocate patients to treatment with either surgical exposure and epineural suture or non-operative treatment in a cast. Due to the nature of treatment arms the allocation will not be blinded. Clinical follow-up and investigation of primary and secondary outcomes will be conducted at 3 weeks, 3 months, 6 months and 1 year after inclusion.


Recruitment information / eligibility

Status Recruiting
Enrollment 166
Est. completion date September 1, 2025
Est. primary completion date September 1, 2025
Accepts healthy volunteers No
Gender All
Age group 20 Years and older
Eligibility Inclusion Criteria: - Clinical signs of isolated traumatic digital nerve injury in digits 2, 3, 4 or 5. - Patient age => 20 years on day of injury. - Injury location on volar aspect of finger. - Acute sensory dysfunction in suspected digital nerve injury area. Exclusion Criteria: - Digital nerve injury ot the thumb - Digital nerve injury in the palm of the hand (i e proximal to the finger base) - Patient does not speak or read the Swedish language. - Abusive drug or alcohol use - Dementia. - Injury mor than 7 days at dianosis AND/OR operative treatment cannot be offered within 10 days from injury. - Neurologic disease. - Ongoing infektion in the injured finger. - concomittant tendoninjury or fracture in injured or adjacent finger. - Injury mechanism is of blunt or crush charachter

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Epineural suture
2 or three sutures
Non-operative treatment
The injured finger is protected in a plaster cast

Locations

Country Name City State
Sweden Karolinska Institutet Södersjukhuset, Department of clinical research and education Stockholm

Sponsors (1)

Lead Sponsor Collaborator
Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Static two points discrimination (S2PD) a static two points discrimination test performed by an occupational therapist of the injured finger one year after injury
Secondary Active range of motion Range of motion of the injured finger (sum of MCP + PIP + DIP joint motion measured in degrees) 3 and 6 months and 1 year
Secondary Ratio between S2PD in injured finger and S2PD in uninjured contralateral finger Ratio between S2PD in injured finger and S2PD in uninjured contralateral finger 3 and 6 months and 1 year
Secondary Semmes-Weinstein monofilament test Discriminatory sensory function as measured by Semmes-Weinstein monofilament test 3 and 6 months and 1 year
Secondary Mini Sollerman test Hand function as measured by the Mini Sollerman test 3 and 6 months and 1 year
Secondary Grip strength Grip strength of injured and non-injured hand as measured by Jamar dynamometer 3 and 6 months and 1 year
Secondary Quick-DASH Patient Rated Outcome measure (PROM) for hand function as measured by the quick-DASH (Disability of the Arm, Shoulder and Hand). 11 items with 5-level Likert scales measures upper limb function. The scale ranges from 0 - 100 and 0 is the lowest possible disability. 3 and 6 months and 1 year
Secondary HQ-8 Patient Rated Outcome measure (PROM) for hand function as measured by the HQ-8 (Eight item HAKIR questionnaire) 3 and 6 months and 1 year
Secondary Neuropathic pain Occurrence of neuropathic pain as measured by Doleur Neuropathic 4 questions (DN4). 4 aspects of neuropathic pain are evaluated by 10 questions, with higher scores representing a worse state. 3 and 6 months and 1 year
Secondary Anxiety and depression Psychologic wellbeing as measured by Hospital Anxiety and Depression scale (HAD) (PCS) at inclusion
Secondary Pain catastrophising scale, (PCS) Pain catastrophising scale, (PCS) measures 13 items on a 5 points Likert scale. Higher scores represent high degree of pain catastrophising scale, (PCS). at inclusion
Secondary Sick leave time Days of absence from work 1 year
Secondary Wait for surgery The number of days that have passed from the day of injury to the day of surgery are reported 3 weeks
Secondary Time in operating theatre Time in operating theatre is measured in minutes day of surgery
See also
  Status Clinical Trial Phase
Completed NCT05337917 - Digital Nerve Injury - a Case Control Study
Terminated NCT05343143 - NeuraGen 3D Pilot Study N/A
Recruiting NCT04115982 - Vitamin D3 in Sensory Recovery After Digital NERVe Suture (D3NERV). Phase 3
Completed NCT05269719 - Epidemiology of Digital Nerve Injuries in the Stockholm County
Active, not recruiting NCT04327154 - TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial N/A